Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2008 1
2009 4
2010 3
2012 3
2013 1
2014 1
2015 6
2016 4
2017 2
2018 1
2019 8
2020 14
2021 6
2022 2
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Results by year

Filters applied: . Clear all
Page 1
Drug repositioning: a brief overview.
Jourdan JP, Bureau R, Rochais C, Dallemagne P. Jourdan JP, et al. Among authors: rochais c. J Pharm Pharmacol. 2020 Sep;72(9):1145-1151. doi: 10.1111/jphp.13273. Epub 2020 Apr 17. J Pharm Pharmacol. 2020. PMID: 32301512 Free PMC article. Review.
hERG toxicity assessment: Useful guidelines for drug design.
Garrido A, Lepailleur A, Mignani SM, Dallemagne P, Rochais C. Garrido A, et al. Among authors: rochais c. Eur J Med Chem. 2020 Jun 1;195:112290. doi: 10.1016/j.ejmech.2020.112290. Epub 2020 Apr 3. Eur J Med Chem. 2020. PMID: 32283295 Review.
5-HT4R modulators: a patent landscape.
Dallemagne P, Rochais C. Dallemagne P, et al. Among authors: rochais c. Pharm Pat Anal. 2021 Jul;10(4):179-181. doi: 10.4155/ppa-2021-0017. Epub 2021 Aug 9. Pharm Pat Anal. 2021. PMID: 34365797 No abstract available.
Facing the complexity of Alzheimer's disease.
Dallemagne P, Rochais C. Dallemagne P, et al. Among authors: rochais c. Future Med Chem. 2020 Feb;12(3):175-177. doi: 10.4155/fmc-2019-0310. Epub 2019 Nov 21. Future Med Chem. 2020. PMID: 31747794 Free article. No abstract available.
Therapeutic Potential of 5-HT6 Receptor Agonists.
Karila D, Freret T, Bouet V, Boulouard M, Dallemagne P, Rochais C. Karila D, et al. Among authors: rochais c. J Med Chem. 2015 Oct 22;58(20):7901-12. doi: 10.1021/acs.jmedchem.5b00179. Epub 2015 Jul 2. J Med Chem. 2015. PMID: 26099069 Review.
Advances in prodrug design for Alzheimer's disease: the state of the art.
Travers-Lesage V, Mignani SM, Dallemagne P, Rochais C. Travers-Lesage V, et al. Among authors: rochais c. Expert Opin Drug Discov. 2022 Apr;17(4):325-341. doi: 10.1080/17460441.2022.2031972. Epub 2022 Feb 23. Expert Opin Drug Discov. 2022. PMID: 35089846 Review.
55 results